Table 4.
Dose (μM) | Trypsin inhibitor (SP3SU2) | trypsin inhibitor (SP2SU2) | ||||
---|---|---|---|---|---|---|
L1210 cells | MBL2 cells | HIV-1 RT | L1210 cells | MBL2 cells | HIV-1 RT | |
100 | 93.2 ± 5.7a | 4.8 ± 1.5 | 3.8 ± 0.6 | 88.1 ± 7.2a | 5.0 ± 1.4 | 5.0 ± 0.8 |
50 | 79.3 ± 5.0b | 2.7 ± 0.7 | 5.3 ± 1.1 | 68.6 ± 5.3b | 4.1 ± 0.8 | 4.7 ± 1.0 |
25 | 56.0 ± 3.8c | 3.4 ± 1.2 | 3.4 ± 1.3 | 44.9 ± 3.4c | 3.5 ± 1.5 | 4.5 ± 1.3 |
12.5 | 24.7 ± 3.1d | 4.2 ± 0.9 | 4.0 ± 1.8 | 21.3 ± 2.2d | 4.3 ± 1.0 | 3.1 ± 0.6 |
Different alphabets (e.g., a, b, c, and d) indicate statistically significant difference (P < .05) when data were analyzed by analysis of variance followed by Duncan's multiple range test.